Stock Market & Financial Investment News

News Breaks October 5, 2012 07:27 EDT ILMN Credit Suisse assesses potential M&A prices for Illumina Credit Suisse said a potential acquisition range for Illumina is $60-$70 per share given recent public and private deals in the tools and diagnostics space. Shares are Outperform rated with a $55 price target. News For ILMN From The Last 14 Days Check below for free stories on ILMN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 10, 2013 07:24 EDT ILMN European Society of Human Genetics to host a conference Subscribe for More Information 06:42 EDT ILMN Illumina removed from U.S. Focus List at Credit Suisse Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.